Robot-assisted vs. laparoscopic-assisted surgery for choledochal cyst in children: a systematic review and meta-analysis

Objective Comprehensive analyses specifically comparing robot-assisted surgery(RS) and laparoscopic surgery(LS) for choledochal cyst(CC) in children remained scarce. This study aimed to evaluate the safety and efficacy of RS vs. LS for pediatric CC. Methods A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted to identify studies published up to December 31, 2025, that compared laparoscopic and robot-assisted surgery for CC in children. Meta-analysis was performed using Stata 18. Results A total of 19 retrospective studies were included. Meta-analysis results demonstrated that the RS group had significantly lower incidences of postoperative biliary stones (OR = 0.10, 95% CI: 0.01–0.89), bile leakage (OR = 0.28, 95% CI: 0.11–0.70), anastomotic stricture (OR = 0.27, 95% CI: 0.12–0.65), and overall complications (OR = 0.26, 95% CI: 0.13–0.51) compared to the LS group. Total operative time was longer in the RS group (SMD = 1.02; 95% CI: 0.30–1.74), whereas intraoperative blood loss was significantly lower (SMD = −1.22; 95% CI: −2.19 to −0.24). Additionally, the RS group exhibited shorter hepaticojejunostomy time (SMD = −1.43; 95% CI: −2.30 to −0.56), drainage tube indwelling time (SMD = −0.74; 95% CI: −1.01 to −0.47), postoperative fasting time (SMD = −0.80; 95% CI: −1.11 to −0.50), and hospital stay (SMD = −1.16; 95% CI: −2.08 to −0.23). No significant differences were observed in other outcomes, including postoperative cholangitis (OR = 0.59, 95% CI: 0.22–1.57), residual cyst (OR = 0.22, 95% CI: 0.02–1.94), incision infection (OR = 0.17, 95% CI: 0.02–1.41), intestinal obstruction (OR = 0.97, 95% CI: 0.40–2.33), pancreatitis (OR = 0.74, 95% CI: 0.08–6.47), pancreatic leakage (OR = 0.43, 95% CI: 0.10–1.92), and conversion to open surgery (OR = 0.79, 95% CI: 0.36–1.75). Furthermore, no statistically significant difference was found in cyst excision time between the two groups (SMD = −1.77; 95% CI: −3.91 to −0.77). Conclusion In the treatment of pediatric CC, RS offered potential advantages over LS in terms of reducing postoperative biliary-related complications, decreasing intraoperative blood loss, accelerating postoperative gastrointestinal function recovery, and shortening hospital stay. Although RS required longer operative time, this limitation might be mitigated with accumulated surgical experience and technological advancements. However, current evidence is primarily derived from retrospective studies conducted in Asian countries and lacked long-term follow-up data. Well-designed multicenter prospective studies or randomized controlled trials were urgently needed to provide higher-level evidence and further validate our findings.

Authors

Institutions

Publication Details

Journal
Frontiers in Pediatrics
Published
2026-04-28
DOI
https://doi.org/10.3389/fped.2026.1811576
Primary Topic
Pediatric Hepatobiliary Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Robot-assisted vs. laparoscopic-assisted surgery for choledochal cyst in children: a systematic review and meta-analysis

Ke Zhang, Fei Liu
Frontiers in Pediatrics
Pediatric Hepatobiliary Diseases and Treatments
article

Robot-assisted vs. laparoscopic-assisted surgery for choledochal cyst in children: a systematic review and meta-analysis

Ke Zhang, Fei Liu
article en

Abstract

Objective Comprehensive analyses specifically comparing robot-assisted surgery(RS) and laparoscopic surgery(LS) for choledochal cyst(CC) in children remained scarce. This study aimed to evaluate the safety and efficacy of RS vs. LS for pediatric CC. Methods A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted to identify studies published up to December 31, 2025, that compared laparoscopic and robot-assisted surgery for CC in children. Meta-analysis was performed using Stata 18. Results A total of 19 retrospective studies were included. Meta-analysis results demonstrated that the RS group had significantly lower incidences of postoperative biliary stones (OR = 0.10, 95% CI: 0.01–0.89), bile leakage (OR = 0.28, 95% CI: 0.11–0.70), anastomotic stricture (OR = 0.27, 95% CI: 0.12–0.65), and overall complications (OR = 0.26, 95% CI: 0.13–0.51) compared to the LS group. Total operative time was longer in the RS group (SMD = 1.02; 95% CI: 0.30–1.74), whereas intraoperative blood loss was significantly lower (SMD = −1.22; 95% CI: −2.19 to −0.24). Additionally, the RS group exhibited shorter hepaticojejunostomy time (SMD = −1.43; 95% CI: −2.30 to −0.56), drainage tube indwelling time (SMD = −0.74; 95% CI: −1.01 to −0.47), postoperative fasting time (SMD = −0.80; 95% CI: −1.11 to −0.50), and hospital stay (SMD = −1.16; 95% CI: −2.08 to −0.23). No significant differences were observed in other outcomes, including postoperative cholangitis (OR = 0.59, 95% CI: 0.22–1.57), residual cyst (OR = 0.22, 95% CI: 0.02–1.94), incision infection (OR = 0.17, 95% CI: 0.02–1.41), intestinal obstruction (OR = 0.97, 95% CI: 0.40–2.33), pancreatitis (OR = 0.74, 95% CI: 0.08–6.47), pancreatic leakage (OR = 0.43, 95% CI: 0.10–1.92), and conversion to open surgery (OR = 0.79, 95% CI: 0.36–1.75). Furthermore, no statistically significant difference was found in cyst excision time between the two groups (SMD = −1.77; 95% CI: −3.91 to −0.77). Conclusion In the treatment of pediatric CC, RS offered potential advantages over LS in terms of reducing postoperative biliary-related complications, decreasing intraoperative blood loss, accelerating postoperative gastrointestinal function recovery, and shortening hospital stay. Although RS required longer operative time, this limitation might be mitigated with accumulated surgical experience and technological advancements. However, current evidence is primarily derived from retrospective studies conducted in Asian countries and lacked long-term follow-up data. Well-designed multicenter prospective studies or randomized controlled trials were urgently needed to provide higher-level evidence and further validate our findings.

Frontiers in PediatricsVol. 14
Taizhou Second People's Hospital (CN), Second People Hospital of Hunan (CN)
Good health and well-being
Openalex Percentile: Top 14%
Pediatric Hepatobiliary Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.